Ortung von Implantierbarer Leitung mittels Ecap

EP3991784 Art B1 6. März 2024

Anmelder: Medtronic, Inc. 🇺🇸

Details

Veröffentlichungs-Nr.
EP3991784
Aktenzeichen
EP21201439
Anmeldetag
7. Oktober 2021
Veröffentlichung
6. März 2024
Erteilung
6. März 2024
Rechtsraum
EP
IPC
A61N1/36// A61N1/05A61N1/375A61N1/372
Offizieller Volltext

Abstract

Systems, devices, methods, and techniques are described for using evoked compound action potential (ECAP) signals to determine an implant location for a lead. An example method includes receiving first information representative of a first evoked compound action potential (ECAP) signal sensed in response to a first control stimulus delivered to a first location adjacent to a spinal cord of a patient. The method also includes receiving, second information representative of a second ECAP signal in response to a second control stimulus delivered to a second location adjacent to the spinal cord of the patient. Additionally, the method includes outputting a first indication of the first information representative of the first ECAP signal and a second indication of the second information representative of the second ECAP signal.

Anmelder

Firma
Medtronic, Inc.
Land
🇺🇸 USA
🇺🇸 Medtronic

US-amerikanischer Medizintechnikkonzern, entwickelt Implantate, Geräte und Therapiesysteme unter anderem für Herz-Kreislauf-, Diabetes- und neurologische Erkrankungen.

4.790 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen